Antimicrobials 2018
 
Antimicrobials 2018 Plenary and Keynote Speakers


Plenary Speakers

Professor Greg Cook
University of Otago, New Zealand

Greg Cook is a world-leading authority on the metabolism and energetics of microbial growth. The overall goal of his research is to develop bacterial metabolism and energetics as a new target space for drug development to combat antimicrobial-resistant bacterial pathogens in humans and animals.


Professor Matthew Holden
University of St Andrews, United Kingdom

Matt Holden is a Professor of Bacterial Genomics in the School of Medicine at the University of St Andrews, and honorary consultant with NHS National Services Scotland. Dr Holden runs a group focusing on experimental and translational genomics and is the genomics lead on the Scottish Healthcare Associated Infections Prevention Institute consortium. His research interests include the evolution of antibiotic resistance and the epidemiology of nosocomial infections.


Professor Lance Price
George Washington University, United States of America

Lance Price is a Professor at the George Washington University’s Milken Institute School of Public Health in Washington DC. He is also the founding director of the Antibiotic Resistance Action Center. Dr. Price works at the interface between science and policy to address the growing crisis of antibiotic resistance. In the laboratory, Dr. Price uses cutting-edge molecular approaches to trace the origins of antibiotic-resistant bacteria and develop strategies to block their transmission. In the policy arena, Dr. Price works with non-governmental organizations and policymakers to develop science-based policies to curb antibiotic abuse in food-animal production. Dr. Price’s works has been covered in media outlets around the world. Dr. Price has a Bachelor’s and Master’s Degree from the Department of Biology at Northern Arizona University and a PhD from the Johns Hopkins Bloomberg School of Public Health.



Keynote Speakers

A/Professor Kirsty Buising
Royal Melbourne Hospital, Australia

Associate Professor Kirsty Buising is an infectious diseases physician working for the Victoria Infectious Diseases Service (VIDS). She is Deputy Director of the National Centre for Antimicrobial Stewardship and chief investigator for the National Health and Medical Research Council (NHMRC) funded Centre for Research Excellence in Antimicrobial Stewardship. Kirsty also holds an appointment as a clinical research physician at VIDS leading the research and development for the Guidance group. Kirsty serves on advisory groups at state, national and international levels in the areas of antimicrobial stewardship, guideline development and healthcare associated infection.


Assistant Research Professor Cindy Liu
George Washington University, United States of America 

Cindy Liu, MD, MPH, PhD, is an Assistant Research Professor in the Department of Environmental and Occupational Health and Chief Medical Officer of Antibiotic Resistance Action Center at the George Washington Milken Institute School of Public Health in Washington DC. The translational goals of her research are to advance our understanding of the role of the microbiome in modifying host susceptibility to pathogens such as HIV and Staphylococcus aureus, with the goal of leveraging this knowledge to develop novel microbiome-based preventive strategies. Her other research focuses on reducing antibiotic-resistant infections through improving antimicrobial stewardship and the development of rapid diagnostics. 

Cindy completed her residency in Clinical Pathology at Johns Hopkins. She received her medical degree from New York University School of Medicine. She also holds a Doctorate of Philosophy in Biology from Northern Arizona University, a Masters in Public Health from The Johns Hopkins Bloomberg School of Public Health, and Bachelor of Arts in International Studies from The Johns Hopkins University. 


Dr Sally Roberts
Auckland District Health Board, New Zealand

Dr Sally Roberts is a graduate of the University of Auckland School of Medicine graduating in 1989. She is a Clinical Microbiologist and Infectious Diseases Physician at Auckland City Hospital and is the Clinical Head of Microbiology at LabPlus, Auckland District Health Board (DHB). Dr Roberts has been on a number of New Zealand Ministry of Health working groups including the MRSA Guidelines Working Group (2002), Chair of the National Antenatal HIV Screening Implementation Advisory Group (2005 onwards), Pandemic Influenza Technical Advisory Group, and Tuberculosis Working Group. Since August 2011 she has been working with the Health Quality & Safety Commission as the Clinical Lead for the Infection Prevention and Control programmes.


Associate Professor Natalie Schellack
Sefako Makgatho Health Sciences University, South Africa

Associate Professor Natalie Schellack is the acting Division Head of Clinical Pharmacy in the School of Pharmacy, Sefako Makgatho Health Sciences University. She holds three degrees, two bachelor degrees (nursing and pharmacy). She is part of the National Department of Health's paediatric essential medicine committee and the Tertiary/Quarternary Committee and serves on the Gauteng Provincial Pharmacy and Therapeutics Committee, and Sefako Makgatho Health Sciences Research and Ethics Committee. She is also the chairperson of the South African Society of clinical pharmacy. Natalie has supervised 50 master's degree students to completion. She has served as an external examiner to the Universities of Witwartersrand, Kwazulu-Natal, North-West and Nelson Mandela Metropolitan. She has written over 100 publications in the last six years and has successfully completed the course in Good Clinical Practice (GCP). In March 2017, Natalie was awarded the Newton Grant ENhancing Appropriate AntimicroBial use via mHeaLth and other techniques in the Republic of South Africa (ENAABLERS) Project.


Professor Mark Wilcox
The University of Leeds, United Kingdom

Professor Mark Wilcox is a Consultant Microbiologist, Head of Research and Development in Microbiology at the Leeds Teaching Hospitals (LTHT), Professor of Medical Microbiology at the University of Leeds (Leeds Institute of Molecular Medicine) and is the Lead on Clostridium difficile for the Public Health England (PHE). Medical Advisor to National Infection Prevention & Control Lead (NHS Improvement), England.

Professor Wilcox heads the Healthcare Associated Infection research team at the University of Leeds, comprising ~30 doctors, scientists and nurses; projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, staphylococcal infection, and the clinical development of new antimicrobial agents. He has a track record of translational research, including providing the basis of clinical advice to the NHS, and influencing infection management policies internationally. From 2017, he co-leads the EU IMI COMBACT-CDI consortium research project. He has been the Principal/UK Investigator for 14 clinical trials of new anti-infective drugs, 1999-2016, has carried out multiple NIHR portfolio studies on healthcare associated infection topics and is currently supplying central laboratory services for several clinical trials of antimicrobial agents. He has authored more than 430 papers and published a number of books and chapters. He is co-editor of Antimicrobial Chemotherapy (5th/6th/7th Eds, 2007/12/15).


Doctor Trent Yarwood
University of Queensland, Australia

Trent is an infectious diseases physician at Cairns Hospital, where he is responsible for the antimicrobial stewardship program. He also sees patients at the Cairns Sexual Health clinic where he has an interest in managing HIV+ patients with medical comorbidities. Trent is undertaking post-fellowship training in public health medicine as part of the communicable disease control team at Tropical Public Health Services (Cairns). His current research is on Group A Streptococcal skin diseases, and medical staff attitudes towards antibiotic prescribing and antibiotic resistance. His other clinical interests are infection control in healthcare settings and in communicable disease epidemiology. Trent is an adjunct Senior Lecturer with the James Cook University School of Medicine & Dentistry, and an Associate Lecturer with the University of Queensland Rural Clinical School. He has two children and is a member of the JCU Fencing Squad.